Coleman Mark plan to sell securities of Axsome Therapeutics, Inc. under Form 144

Coleman Mark filed Form 144 to notify SEC of plan to sell 6000 units of Axsome Therapeutics, Inc. securities around 2026-05-29, with aggregate market value of $1,400,783.00. The total outstanding units is 51459766.0. The amount planned to be sold represents 0.01% of total outstanding units;